Akkermansia muciniphila: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
Only pasteurised Akkermansia muciniphila is approved as a Novel Food by EFSA, at levels not exceeding 5 x 10<sup>10</sup> (which is 50 billion) and maximum doses of 3.4 x 10<sup>10</sup> (34 billion). | Only pasteurised Akkermansia muciniphila is approved as a Novel Food by EFSA, at levels not exceeding 5 x 10<sup>10</sup> (which is 50 billion) and maximum doses of 3.4 x 10<sup>10</sup> (34 billion). | ||
https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32022R0168 | |||
The company A-Mansia Biotech S.A. have an exclusive until 1/3/2027, so no other versions can be sold until after that date. They only sell their own brand and have not replied to any emails. | The company A-Mansia Biotech S.A. have an exclusive until 1/3/2027, so no other versions can be sold until after that date. They only sell their own brand and have not replied to any emails. | ||
https://www.theakkermansiacompany.com/ | |||
[[Category:Ingredients]] | |||
[[Category:Novel Food]] | |||
Latest revision as of 13:11, 18 June 2026
Only pasteurised Akkermansia muciniphila is approved as a Novel Food by EFSA, at levels not exceeding 5 x 1010 (which is 50 billion) and maximum doses of 3.4 x 1010 (34 billion). https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32022R0168
The company A-Mansia Biotech S.A. have an exclusive until 1/3/2027, so no other versions can be sold until after that date. They only sell their own brand and have not replied to any emails. https://www.theakkermansiacompany.com/